Drug Resistance in Cancer Cells

Nonfiction, Health & Well Being, Medical, Specialties, Oncology, Medical Science, Pharmacology
Cover of the book Drug Resistance in Cancer Cells by , Springer New York
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: ISBN: 9780387894454
Publisher: Springer New York Publication: June 12, 2009
Imprint: Springer Language: English
Author:
ISBN: 9780387894454
Publisher: Springer New York
Publication: June 12, 2009
Imprint: Springer
Language: English

It was estimated that in 2008, 1,437,180 patients would receive a new cancer diagnosisand 565,650individualswould die of cancer (Jemal et al. 2008).Since the vast majority of patients dying of cancer will have had anticancer therapy, both c- ventional chemotherapy and novel targeted therapy, it can be concluded that these patients are dying with drug resistant cancer. The term multidrug resistance is also apt – in that these patients die after having undergone multiple rounds of different and structurally unrelated cancer therapies. However, for some, the concept of m- tidrug resistance is a worn out idea, stemming from disappointment with the drug resistancereversalstrategiesthatwerecarriedoutinthe1990susingpumpinhibitors to block drug resistance mediated by P-glycoprotein, product of the MDR-1 gene. However, if one takes the larger de?nition – multidrug resistance as simultaneous resistance to multiple structurally unrelated anticancer therapies – its existence c- not be denied. The purpose of this book is to explore new concepts related to drug resistance in cancer, including resistance to the new molecularly targeted agents. Perhaps new terminology is needed for resistance that occurs following therapy with the targeted agents: Novel Targeted Agent Resistance (NTR). Alternatively, we can return to the original de?nition of multidrug resistance as simply the res- tance to multipleagents that occurs in the course of normalcancer progression.This resistance is likely to be mediated by many factors.

View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

It was estimated that in 2008, 1,437,180 patients would receive a new cancer diagnosisand 565,650individualswould die of cancer (Jemal et al. 2008).Since the vast majority of patients dying of cancer will have had anticancer therapy, both c- ventional chemotherapy and novel targeted therapy, it can be concluded that these patients are dying with drug resistant cancer. The term multidrug resistance is also apt – in that these patients die after having undergone multiple rounds of different and structurally unrelated cancer therapies. However, for some, the concept of m- tidrug resistance is a worn out idea, stemming from disappointment with the drug resistancereversalstrategiesthatwerecarriedoutinthe1990susingpumpinhibitors to block drug resistance mediated by P-glycoprotein, product of the MDR-1 gene. However, if one takes the larger de?nition – multidrug resistance as simultaneous resistance to multiple structurally unrelated anticancer therapies – its existence c- not be denied. The purpose of this book is to explore new concepts related to drug resistance in cancer, including resistance to the new molecularly targeted agents. Perhaps new terminology is needed for resistance that occurs following therapy with the targeted agents: Novel Targeted Agent Resistance (NTR). Alternatively, we can return to the original de?nition of multidrug resistance as simply the res- tance to multipleagents that occurs in the course of normalcancer progression.This resistance is likely to be mediated by many factors.

More books from Springer New York

Cover of the book Psychosomatic Medicine by
Cover of the book Perinatal and Prenatal Disorders by
Cover of the book The Somatotrophic Axis and the Reproductive Process in Health and Disease by
Cover of the book Molecular Genetics of Axial Patterning, Growth and Disease in the Drosophila Eye by
Cover of the book Clinical Aspects of Electroporation by
Cover of the book From Kinetic Models to Hydrodynamics by
Cover of the book Menahem Max Schiffer: Selected Papers Volume 1 by
Cover of the book Reviews of Environmental Contamination and Toxicology by
Cover of the book The Organization of Critical Care by
Cover of the book Multisensory Object Perception in the Primate Brain by
Cover of the book Modern Issues and Methods in Biostatistics by
Cover of the book From Human Attention to Computational Attention by
Cover of the book The Quality of Measurements by
Cover of the book A Dictionary of Hallucinations by
Cover of the book Global Perspectives on Social Capital and Health by
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy